Token test - validační studie české verze u osob vyššího věku a pacientů s neurodegenerativním onemocněním mozku
| Title in English | Token test - Validation Study in Older Czech Adults and Patients with Neurodegenerative Diseases |
|---|---|
| Authors | |
| Year of publication | 2017 |
| Type | Article in Periodical |
| Magazine / Source | Česká a slovenská neurologie a neurochirurgie |
| MU Faculty or unit | |
| Citation | |
| web | http://www.csnn.eu/ceska-slovenska-neurologie-clanek/token-test-validacni-studie-ceske-verze-u-osob-vyssiho-veku-a-pacientu-s-neurodegenerativnim-onemocnenim-mozku-60991 |
| Doi | http://dx.doi.org/10.14735/amcsnn2017300 |
| Field | Psychology |
| Keywords | Token Test- reliability and validity-Alzhemer's disease-Parkinson's disease-mild cognitive impairment |
| Description | Aim: The study examines psychometric properties of the Czech version of the Token Test (TT) on a population of Czech seniors and individuals with neurodegenerative brain diseases. Participants and methods: The study included 96 individuals (mean age 67.7 years), of whom 43 were healthy controls (HC), 23 had incipient Alzheimer’s disease or mild cognitive impairment due to Alzheimer’s disease (AD + MCI), and 30 had Parkinson’s disease (PD). Results: Signifi cant diff erences in TT performance were found between the sample groups HC and AD + MCI and between PD and AD + MCI (. The highest convergent validity of TT was with the immediate reproduction of the Rey-Osterrieth complex fi gure , the Boston Naming Test and the Mississippi Aphasia Screening Test . ROC analysis showed TT to discriminate with high precision for AD + MCI (AUC = 0.826), not for PN (AUC = 0.826). Conclusion: TT does not selectively evaluate the language function as such but it is selective for neurogenic communication disorders in patients with neurodegenerative brain disease. |
| Related projects: |